Clinical Trial Update: Phase 1/2 Clinical Study of TPX-115 in Patients With Partial-Thickness Rotator Cuff Tear [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical study of TPX-115 for partial-thickness rotator cuff tear has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rotator Cuff Injuries

Drugs mentioned

• TPX-115 (TPX-115)

Snippet

Sponsor: Tego Science, Inc. | Conditions: Rotator Cuff Injuries | Phase 1, Phase 2 | Status: COMPLETED